» Articles » PMID: 30993104

Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study

Overview
Date 2019 Apr 18
PMID 30993104
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The use of platelet-rich plasma (PRP) for the treatment of nonhealing ulcers is a relatively new technique. Although it seems to result in a satisfying level of healing and low complication rates, data regarding its effectiveness remain sparse. This study aims to evaluate the potential therapeutic effects of PRP on chronic nonhealing ulcers.

Materials And Methods: This was a prospectively designed study comparing outcomes between patients treated with PRP (Group A, n=15) and patients treated conventionally (Group B, n=12) for different types of nonhealing ulcers. In Group A, PRP was produced from the patients' own peripheral blood samples and was applied on the ulcer once every week. In Group B, patients were treated conventionally, without applying PRP. The total treatment period was 5 weeks.

Results: Both groups were similar regarding age, sex, comorbidities, and time of treatment. In Group A, patients showed a nonsignificant reduction of 4.5 mm in ulcer area (P=0.190) and a reduction of more than 1 mm in depth (P=0.0006), while Group B showed an increase of 108±80.5 mm in ulcer area after 5 weeks (P=0.016). The healing rate (HR) in Group A was stable and positive throughout the treatment period, while HR in Group B was initially negative but became positive after the 3rd week.

Conclusion: PRP application once a week promotes the healing of chronic ulcers. It improves the ulcer's depth and HR, although its effect on ulcer area seems to be nonsignificant. However, larger comparative series are still needed to confirm these findings.

Citing Articles

Medical Management to Treat Chronic Non-healing Ulcers: A Case Series.

Jose J, Soni B, Jose S, Kokkatt J Cureus. 2024; 16(1):e51449.

PMID: 38169779 PMC: 10758169. DOI: 10.7759/cureus.51449.


An In-Vivo Study of Effects of Platelet-Rich Plasma on Transforming Growth Factor-β1 and Matrix Metalloprotein 9 Expression in Traumatic Ulcers with Diabetes Mellitus.

Radithia D, Yuliana Y, Puspitasari Y, Sismiyanti R, Pratiwi A Eur J Dent. 2023; 18(1):214-218.

PMID: 37172947 PMC: 10959589. DOI: 10.1055/s-0043-1764429.


Platelet-Rich Plasma in Chronic Wound Management: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Meznerics F, Fehervari P, Dembrovszky F, Kovacs K, Kemeny L, Csupor D J Clin Med. 2022; 11(24).

PMID: 36556151 PMC: 9785167. DOI: 10.3390/jcm11247532.


Radiofrequency ablation of varicose veins in combination with ultrasonic-assisted wound debridement and platelet-rich plasma as well as platelet-rich fibrin technologies in treatment of lower extremity venous ulcers in office-based surgery.

Goshchynsky V, Svidersky Y, Migenko B, Pyatnychka O Pan Afr Med J. 2022; 42:154.

PMID: 36187047 PMC: 9482222. DOI: 10.11604/pamj.2022.42.154.29834.


Efficacy of Local Autologous Platelet-Rich Plasma in the Treatment of Pressure Ulcer in Spinal Cord Injury Patients.

Singh G, Borah D, Khanna G, Jain S Cureus. 2021; 13(10):e18668.

PMID: 34790446 PMC: 8583427. DOI: 10.7759/cureus.18668.


References
1.
Vanwijck R . [Surgical biology of wound healing]. Bull Mem Acad R Med Belg. 2002; 156(3-4):175-84; discussion 185. View

2.
Bhanot S, Alex J . Current applications of platelet gels in facial plastic surgery. Facial Plast Surg. 2002; 18(1):27-33. DOI: 10.1055/s-2002-19824. View

3.
Pietrzak W, Eppley B . Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005; 16(6):1043-54. DOI: 10.1097/01.scs.0000186454.07097.bf. View

4.
Anitua E, Sanchez M, Nurden A, Nurden P, Orive G, Andia I . New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006; 24(5):227-34. DOI: 10.1016/j.tibtech.2006.02.010. View

5.
Vick V, Holds J, Hartstein M, Rich R, Davidson B . Use of autologous platelet concentrate in blepharoplasty surgery. Ophthalmic Plast Reconstr Surg. 2006; 22(2):102-4. DOI: 10.1097/01.iop.0000202092.73888.4c. View